Genmab — Februar 2025
-
Ja 20-30 er for lidt.
CD-38 eksisterer ikke i dagens kurs. Men naturligvis vil aktien reagere negativt på et nej. Til gengæld kan vi kigge fremad og investorerne orientere sig uden den risiko. Det vil absolut ikke undre mig, hvis vi efter lidt tid ligger en del højere end i dag. Men - hvad ved jeg
men hvis jeg selv skal sige det højt, så har mine gæt og valg m.h.t. Aktiehandel ligget væsentligt over de 50% 
-
Der kan kun være en forklaring på den slags gentagelser... - De er blandt de såkaldte spekulanter.... Lur mig de kommer til at tjene kassen.... Ellers synes jeg da bare de skulle have shortet den hver gang de er kommet med disse udmeldinger.... Nåh nej, det virker jo ikke til at skurkene vil tjene penge...
-
Godmorgen

-
Not so fun fact: Der er udstedt 20mill aktier siden 2012 og det stopper ikke. Buyback sletter ikke aktier. https://www.macrotrends.net/stocks/charts/GNMSF/genmab/shares-outstanding
-
Novo Nordisk A/S: Once-weekly Mim8 is well-tolerated and efficacious in children living with haemophilia A with and without inhibitors
Phase 3 FRONTIER3 interim analysis data presented at EAHAD 2025 showed that 74.3% of children on once-weekly Mim8 prophylaxis experienced zero treated bleeds Bagsværd, Denmark, 7 February 2025 – Novo Nordisk today announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with haemophilia A with and without inhibitors. The trial initially assessed once-weekly prophylaxis treatment (regular treatment to prevent prolonged and spontaneous bleeding) with investig
Yahoo Finance (finance.yahoo.com)
-
i didn't realise they were this far in children already. Let's hope Novo can speed up the regulatory submission a bit. "At week 26, 98% of caregivers said they preferred Mim8 to prior treatment, of which 73% said they ‘very strongly’ preferred Mim8 to prior treatment."
-
Novo Nordisk adds pediatric data to bulging bag of evidence on near-approval hemophilia A prospect https://www.fiercebiotech.com/biotech/novo-adds-pediatric-data-bulging-bag-evidence-near-approval-hemophilia-prospect
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind